0
You can donate money to support the Her2 Breast cancer foundation. You can even participate in the marathons they have and or you can supply Breast cancer patients with supplies.
Wiki User
∙ 11y ago
Add your answer:
Earn +20 pts
What is the website Her2 breast cancer for?
This website offers its user access to information, stories, and message boards containing the accounts of other women with the same cancer. HER2/neu refers to a specific mutation that is found in certain breast cancers.
What exactly is HER2 breast cancer and what treatments are available?
"HER2 breast cancer is named for the gene that helps cells grow, divide and repair. If a woman has cancer in this gene it grows faster and has a greater chance of returning. Treatments available for this type of cancer include chemotherapy, radiation therapy and a lumpectomy or mastectomy."
Is her2 positive cancer aggresive?
Her2 is more aggressive than other breast cancers because hormone treatment is less effective than if you used the treatment on other types of breast cancers.
What is the triple negative breast cancer cell?
Negative for estrogen receptors (ER-), progesterone receptors (PR-), and HER2 (HER2-). Testing negative for all three means the cancer cell is triple-negative.
What is Triple Negative Breast Cancer?
Triple negative breast cancer (TNBC) is a subtype of breast cancer. This form of cancer lacks three receptors, namely the estrogen, progesterone, and HER2 receptors. Therefore it becomes unresponsive to hormonal and HER2-targeted therapies, meaning that convential breast cancer drugs show reduced efficacy. On our website for human biospecimen we gathered more information about TNBC. Have a look here: centralbiohub.de/biospecimens/cancer-samples/triple-negative-breast-cancer
What type of cancer did Elizabeth Edwards die from?
Elizabeth Edwards had breast cancer that had spread to other parts of her body.
What makes the treatment of Triple Negative Breast Cancer so difficult?
Triple negative breast cancer (TNBC) is a very aggressive subtype of breast cancer, often associated with a bigger size and poorer prognosis. As TNBC lacks three receptors, namely the estrogen, progesterone, and HER2 receptor, it becomes unresponsive to hormonal and HER2-targeted therapies. Therefore, convential breast cancer drugs show reduced efficacy. If you want to learn more about Triple Negative Breast Cancer, have a peek on our website for human biospecimen where we gathered more informations and includes some FAQS: centralbiohub.de/biospecimens/cancer-samples/triple-negative-breast-cancer
How many types of Breast cancer are there?
How many type of breast cancer are there
What has the author Sophie I Williams written?
Sophie I. Williams has written: 'HER2 and cancer' -- subject(s): HER-2 gene, Receptor, erbB-2, Breast, Cancer, Drug Delivery Systems, HER-2 protein, Genetic aspects
How is double negative breast cancer treated?
I believe if means ER-, PR-, and Her2+ Estrogen Receptor, Progesterone Receptor, and the orphan receptor Her2/Neu. So it means that both of the hormone receptors (ER and PR) are not expressed by the tumor, but that other known markers, like Her2 are expressed. Expressing (being positive) is a good thing because it gives the clinicians something to target.
What is Double-Negative Breast Cancer?
I believe if means ER-, PR-, and Her2+ Estrogen Receptor, Progesterone Receptor, and the orphan receptor Her2/Neu. So it means that both of the hormone receptors (ER and PR) are not expressed by the tumor, but that other known markers, like Her2 are expressed. Expressing (being positive) is a good thing because it gives the clinicians something to target.
How do you cure secondary breast cancer?
Secondary breast cancer, also known as metastatic breast cancer, occurs when breast cancer spreads to other parts of the body, typically the bones, liver, lungs, or brain. Unlike early-stage breast cancer, which is often treated with curative intent, the goal of treatment for metastatic breast cancer is typically to manage the disease, control symptoms, and improve the patient's quality of life. While it may not be curable in the traditional sense, it can be treated and managed effectively to extend survival and provide relief from symptoms. Here are some key treatment approaches for secondary breast cancer: Systemic Therapy: Hormone Therapy: If the breast cancer is hormone receptor-positive, hormone therapy can be used to block the hormones (estrogen and progesterone) that fuel the cancer's growth. Targeted Therapy: Targeted therapies, such as HER2-targeted drugs like trastuzumab (Herceptin), are used for HER2-positive breast cancer. Chemotherapy: Chemotherapy may be prescribed to slow the progression of the cancer, reduce symptoms, and improve the patient's quality of life. Immunotherapy: Some immunotherapy drugs are being studied for the treatment of metastatic breast cancer. Radiation Therapy: Radiation therapy may be used to alleviate symptoms and manage pain in cases of metastatic breast cancer that has spread to the bones or other areas. Surgery: In some cases, surgery may be recommended to address specific complications or relieve symptoms. For example, surgery may be performed to stabilize bones affected by cancer metastasis (bone metastases). Clinical Trials: Participation in clinical trials can provide access to new and experimental treatments that may be more effective in managing metastatic breast cancer. Palliative Care: Palliative care focuses on improving the patient's quality of life by managing symptoms, providing pain relief, and offering emotional and psychological support. It is an essential component of care for metastatic breast cancer patients. Lifestyle and Supportive Care: Maintaining a healthy lifestyle, managing side effects of treatment, and seeking emotional support through counseling or support groups can contribute to the overall well-being of patients with metastatic breast cancer. It's important to note that treatment plans for metastatic breast cancer are highly individualized. The choice of treatment depends on factors such as the type of breast cancer, the extent of metastasis, the patient's overall health, and their treatment goals. Patients with metastatic breast cancer often receive ongoing care and may transition between different treatments as needed. While metastatic breast cancer may not be curable in the traditional sense, advancements in treatment have led to improved outcomes and longer survival for many patients. The focus of treatment is on extending life, managing symptoms, and maintaining the best possible quality of life for individuals living with metastatic breast cancer. Regular communication with a healthcare team and access to supportive care services are crucial aspects of managing this condition.
